Angene Chemical
Draw
|
Currency :
Home Products

AG00E9IO

57-47-6 | Physostigmine

Chemical structure of Physostigmine, CAS 57-47-6
AG00E9IO
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 57-47-6
Catalog Number AG00E9IO(AGN-PC-0SNTBT)
Chemical Name Physostigmine
EC Number 200-332-8
IUPAC Name [(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate
InChI InChI=1S/C15H21N3O2/c1-15-7-8-17(3)13(15)18(4)12-6-5-10(9-11(12)15)20-14(19)16-2/h5-6,9,13H,7-8H2,1-4H3,(H,16,19)/t13-,15+/m1/s1
InChI Key PIJVFDBKTWXHHD-HIFRSBDPSA-N
MDL Number MFCD00151090
Molecular Formula C15H21N3O2
Molecular Weight 275.3461
NSC Number 30782
RTECS Number TJ2100000
SMILES C[C@]12C=3C(N(C)[C@]1(N(C)CC2)[H])=CC=C(OC(NC)=O)C3
UNII 9U1VM840SP
Synonyms
Eserine, Physostigmine, physostigmine, Eserine, Antilirium, 57-47-6, Esromiotin, Physostol, Ezerin, Calabarine, Erserine, Fysostigmin, (-)-physostigmine, Fysostigmin [Czech], (3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate, Eserolein, methylcarbamate (ester), UNII-9U1VM840SP, Eserine sulfate, CCRIS 3422, HSDB 3161, MCV 4484, CHEMBL94, EINECS 200-332-8, Eserolein, methylcarbamate, NIH 10421, NSC 30782, RCRA waste no. P204, CS 58525, Methyl-carbamic acid, ester with eseroline, 9U1VM840SP, Carbamic acid, methyl-, ester with eseroline, CHEBI:27953, NSC30782, NCGC00093889-03, DSSTox_CID_3471, 1,2,3,3abeta,8abeta-Hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)-indol-5-yl methylcarbamate, DSSTox_RID_77040, DSSTox_GSID_23471, (3aS-cis)-1,2,3,3a,8,8a-Hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-ol methylcarbamate (ester), CHEMBL537674, Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-, [(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate, CAS-57-47-6, Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS,8aR)-, Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis), Physostigmine [USP:BAN], Physostigmine [USAN:BAN], (-) physostigmine, Eserine (TN), Physostigmine (USP), Spectrum_000916, Spectrum_001789, SpecPlus_000381, AC1L1LJL, Prestwick0_000566, Prestwick1_000566, Prestwick2_000566, Prestwick3_000566, Spectrum2_000330, Spectrum2_000757, Spectrum2_001283, Spectrum3_000545, Spectrum3_000901, Spectrum4_000997, Spectrum4_001631, Spectrum4_001913, Spectrum5_000441, Spectrum5_000626, Spectrum5_001672, physostigmine.salicylic acid, Lopac0_000483, SCHEMBL24044, BSPBio_000352, BSPBio_002189, KBioGR_001433, KBioGR_002061, KBioGR_002533, KBioSS_001396, KBioSS_002279, MLS001304022, DivK1c_006477, SPECTRUM1500753, SPBio_000339, SPBio_000774, SPBio_001285, SPBio_002571, BPBio1_000388, cid_657348, GTPL6598, MEGxp0_001872, DTXSID3023471, ACon1_000097, BDBM11023, KBio1_001421, KBio2_001396, KBio2_002278, KBio2_003964, KBio2_004846, KBio2_006532, KBio2_007414, KBio3_001689, KBio3_001842, Eserine, >=98.0% (N), PIJVFDBKTWXHHD-HIFRSBDPSA-N, HMS1921G06, HMS2089M11, HMS2236L08, HMS3261B07, BCP19735, Carbamic acid, ester with eseroline, Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, 5-(N-methylcarbamate), (3aS,8aR)-, Tox21_111228, Tox21_301591, Tox21_500483, BDBM50004000, BDBM50222010, CCG-38605, MFCD00151090, NSC-30782, ZINC91689892, Tox21_111228_1, API0003840, DB00981, LP00483, MCULE-2638001883, MCULE-9310809074, RP29728, SDCCGMLS-0066585.P001, NCGC00093889-01, NCGC00093889-02, NCGC00093889-04, NCGC00093889-05, NCGC00093889-06, NCGC00093889-07, NCGC00093889-08, NCGC00093889-09, NCGC00093889-10, NCGC00093889-12, NCGC00093889-13, NCGC00255345-01, NCGC00261168-01, AC-15983, AJ-86526, SMR000718753, SBI-0050467.P004, AX8147965, LS-109562, EU-0100483, P0406, C06535, D00196, E 8375, SR-01000075341-1, WLN: T B556 EN GNTT&J B1 E1 G1 KOVM1, BRD-K25650355-001-02-5, BRD-K25650355-059-02-3, BRD-K25650355-059-12-2, (3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate hydrochloride, (3aS,8aR)-1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyrrolo[2,3-b]indol-5-yl N-methylcarbamate, (3aS,8aR)-1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyrrolo[2,3-b]indol-5-yl N-methylcarbamate; 2-hydroxybenzoic acid, Pyrrolo[2, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-, cogmine, Xalieve, Isopto Eserine, Eserine salicylate, Physostigmine salicylate, Eserine hemisulfate salt, ESERINE HEMISULFATE, D09JVV, C15H21N3O2, CID5983, C15-H21-N3-O2, CS-O-11713, Physostigmine (buccal, xerostomia), Calabar, Physostigmine (local acting gel, xerostomia), D010830, SR-01000075341, Acetylcholinesterase inhibitor (dry mouth), Calabar, Physostigmine (local acting gel, xerostomia), Calabar, (3aS,8aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-ylmethylcarbamate, (3aS-cis)-1,2,3,3a,8,8a-Hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-ol methylcarba-mate (ester), Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS,8aR)-, Pyrrolo[2,3-b]indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited